September 2014 FDA Recall Amiodarone Hydrochloride by Mckesson
D-0005-2015 - Temperature Abuse

This Class II drug recall was voluntarily initiated by Mckesson on September 12, 2014 for the product Amiodarone Hydrochloride. The FDA reported the reason for recall as temperature abuse. The product was distributed in McKesson Medical-Surgical Inc distributed to (6) physicians and/or medical facilities in WA, OR, and MT. and the recall is currently terminated.

Recall Number: D-0005-2015

Reason for Recall
Temperature Abuse: One shipment was inadvertantly stored refrigerated rather than the labeled room temperature recommendation at McKesson Medical-Surgical Inc., one of the distributing wholesalers.
Initiated
09-12-2014
Reported
10-15-2014
Quantity
10 vials

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
McKesson Medical-Surgical Inc distributed to (6) physicians and/or medical facilities in WA, OR, and MT.
Amiodarone HCl Injection, 450 mg/9 mL (50 mg per mL), 9 mL Single-Use Vial, Rx only, Manufactured for Mylan Institutional, LLC, Rockford, IL 61103, NDC 67457-153-09.

Batch or Lot Expiration Information

Lot# 140502, Exp 10/31/2015